Moraxella bovoculi em casos de ceratoconjuntivite infecciosa bovina no Rio Grande do Sul / Moraxella bovoculi in cases of infectious bovine keratoconjunctivitis in Rio Grande do Sul, Brazil

A ceratoconjuntivite infecciosa (CI), embora raramente fatal, resulta em perdas econômicas significativas para os rebanhos bovinos e ovinos. Os principais agentes causadores dessa enfermidade são Moraxella bovis e Moraxella ovis. Em 2007 foi descrita uma nova espécie também responsável pela CI e denominada Moraxella bovoculi, que até o presente momento, não havia sido relatada no Brasil. Assim, objetivou-se com este trabalho caracterizar e distinguir 54 isolados de Moraxella spp. de amostras clínicas oriundas de 34 bovinos e 17 ovinos, encaminhadas ao Laboratório de Bacteriologia da Universidade Federal de Santa Maria no período de 1990 a 2011, visando a identificação de M. bovoculi. A distinção dos isolados foi fundamentada nas características genotípicas, pela amplificação parcial da região intergênica 16S-23S e clivagem dos produtos da amplificação com enzima RsaI. Como resultados, 25 (46%) isolados foram caracterizados como M. bovis, 17 (32%) como M. ovis e 12 (22%) como M. bovoculi. Logo, conclui-se que M. bovoculi encontra-se presente no rebanho bovino do Rio Grande do Sul e, portanto, no Brasil.

Infectious keratoconjunctivitis (IK), although rarely fatal, results in significant economic losses for cattle and sheep farmers. The main causative agents of this disorder are Moraxella bovis and Moraxella ovis. In 2007, a new species also responsible for IK was described. This newly described pathogen, called Moraxella bovoculi, was never reported in Brazil. Therefore, the aim of this study was confirmed the M. bovoculi among the samples analyzed. For this, 54 isolates of Moraxella spp. from clinical samples derived from 34 cattle and 18 sheep, sent to the laboratory of bacteriology from 1991 to 2011 was characterized. Differentiation among the species was based on genotypic characteristics, using partial amplification of 16S-23S intergenic region and cleavage products of amplification with enzyme RsaI. Results showed that 25 isolates (46%) were characterized as M. bovis, 17 (32%) as M. ovis, and 12 (22%) as M. bovoculi. This means that M. bovoculi is present among cattle herds in Rio Grande do Sul and, therefore, in Brazil.

An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis.

The potency of genetic immunization observed in the mouse has demonstrated the utility of DNA vaccines to induce cell-mediated and humoral immune responses. However, it has been relatively difficult to generate comparable responses in non-rodent species. The use of molecular adjuvants may increase the magnitude of these suboptimal responses. In this study, we demonstrate that the co-administration of plasmid-encoded GM-CSF and CD80/CD86 with a novel ESAT-6:CFP10 DNA vaccine against bovine tuberculosis enhances antigen-specific cell-mediated immune responses. ESAT-6:CFP10+GM-CSF+CD80/CD86 DNA vaccinated animals exhibited significant (p<0.01) antigen-specific proliferative responses compared to other DNA vaccinates. Increased expression (p< or =0.05) of CD25 on PBMC from ESAT-6:CFP10+GM-CSF+CD80/CD86 DNA vaccinates was associated with increased proliferation, as compared to control DNA vaccinates. Significant (p<0.05) numbers of ESAT-6:CFP10-specific IFN-gamma producing cells were evident from all ESAT-6:CFP10 DNA vaccinated animals compared to control DNA vaccinates. However, the greatest increase in IFN-gamma producing cells was from animals vaccinated with ESAT-6:CFP10+GM-CSF+CD80/CD86 DNA. In a low-dose aerosol challenge trial, calves vaccinated as neonates with Mycobacterium bovis BCG and ESAT-6:CFP10+GM-CSF+CD80/CD86 DNA exhibited decreased lesion severity in the lung and lung-associated lymph nodes following viruluent M. bovis challenge compared to other vaccinated animals or non-vaccinated controls. These data suggest that a combined vaccine regimen of M. bovis BCG and a candidate ESAT-6:CFP10 DNA vaccine may offer greater protection against tuberculosis in cattle than vaccination with BCG alone.

Vesicular stomatitis New Jersey virus (VSNJV) infects keratinocytes and is restricted to lesion sites and local lymph nodes in the bovine, a natural host.

Inoculation of vesicular stomatitis New Jersey virus (VSNJV) by skin scarification of the coronary-band in cattle, a natural host of VSNJV, resulted in vesicular lesions and 6-8 log(10) TCID(50) increase in skin virus titers over a 72 h period. Virus infection was restricted to the lesion sites and lymph nodes draining those areas but no virus or viral RNA was found in the blood or in 20 other organs and tissues sampled at necropsy. Scarification of flank skin did not result in lesions or a significant increase in viral titer indicating that viral clinical infection is restricted to skin inoculation at sites where lesions naturally occur. Viral antigens co-localized primarily with keratinocytes in the coronary band, suggesting these cells are the primary site of viral replication. Viral antigen also co-localized with few MHC-II positive cells, but no co-localization was observed in cells positive for macrophage markers. Although granulocyte infiltration was observed in lesions, little viral antigen co-localized with these cells. This is the first detailed description of VSNJV tissue distribution and infected cell characterization in a natural host. The pathogenesis model shown herein could be useful for in-vivo tracking of virus infection and local immune responses.

Identificaçäo do vírus da Diarréia Viral Bovina tipo 2 (BVDV-2) no Sul do Brasil / Identification of bovine virus diarrhea virus type-2(BVDV-2) in Southern Brazil

Amostras do vírus da Diarréia Viral Bovina (BVDV), denominadas de BVDV tipo 2 (BVDV-2), foram inicialmente identificadas em surtos de BVD aguda e enfermidade hemorrágica e têm sido isoladas predominantemente na América do Norte. O presente artigo descreve dois casos de enfermidade gastroentérica/respiratória seguidos de isolamento e identificaçäo de amostras de BVDV tipo 2 no sul do Brasil. Os vírus foram isolados de duas novilhas de diferentes rebanhos. Um dos animais apresentou enfermidade aguda, cursando com anorexia, atonia ruminal, diarréia escura ou muco-sanguinolenta, tenesmo e descarga nasal muco-purulenta. O outro animal desenvolveu enfermidade de longa duraçäo (7 meses), caracterizada por crescimento retardado, anorexia, quadros recorrentes de diarréia, dermatite interdigital, hemorragias digestivas e genitais ocasionais, conjuntivite, artrite e pneumonia crônica. Congestäo disseminada das mucosas, ulcerações extensivas e profundas na língua, palato e esôfago, áreas necróticas na mucosa do rúmen, áreas de congestäo e ulcerações cobertas com fibrina no intestino delgado foram os achados mais proeminentes. Antígenos do BVDV foram demonstrados por imunohistoquí-mica no epitélio da língua, nos pulmões e em linfonodos mesentéricos. Amostras näo-citopáticas do BVDV foram isoladas em cultivo celular a partir de leucócitos e do baço dos animais afetados e identificadas por imunofluorescência. Caracterizaçäo antigênica e análise filogenética desses isolados, e de outras duas amostras de BVDV isoladas de fetos coletados em matadouros, revelou tratar-se de BVDV tipo 2. A presença do BVDV tipo 2 na populaçäo bovina do Brasil possui um significado epidemiológico importante e pode ter conseqüências para o diagnóstico, estratégias de imunizaçäo e produçäo de vacinas(au)